<DOC>
	<DOCNO>NCT01513200</DOCNO>
	<brief_summary>This phase 1 randomize , double-blind crossover trial enrol approximately 12 healthy volunteer ass whether intravenous ( IV ) UFH IV Bendavia administer together significant impact pharmacodynamic effect UFH pharmacokinetics Bendavia .</brief_summary>
	<brief_title>Study Assess Pharmacodynamic Effects Unfractionated Heparin ( UFH ) Healthy Volunteers With Without Bendavia</brief_title>
	<detailed_description />
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Healthy adult male female age 18 65 year age sign informed consent . Women postmenopausal ( without menstrual bleed &gt; 24 month ) surgically sterile must negative serum pregnancy test screening within 24 hour treatment understanding ( informed consent process ) become pregnant duration study must agree employ effective form birth control duration study [ Acceptable form birth control : doublebarrier contraceptive ( condom , diaphragm spermicide ) intrauterine device ( IUD ) 1 week prior least 30 day post treatment even hormonal contraceptive use ] Serum sodium level lower limit site 's clinical laboratory normal range study period qualification visit , Platelet value lower limit normal range screen admission , aPTT value outside normal range screen admission , Creatinine clearance calculate Cockcroft Gault method calculate &lt; 90 mL/min male &lt; 80 mL/min female , Any addition laboratory abnormality determine clinically significant Principal Investigator laboratory screening , Clinically significant abnormality physical examination , Body Mass Index ( BMI ) less 18 kg/m2 great 32 kg/m2 , Any disease condition might compromise cardiovascular , hematological , renal , hepatic , pulmonary ( include chronic asthma ) , endocrine ( e.g. , diabetes ) , central nervous , gastrointestinal ( include ulcer ) system , History seizures history epilepsy , History serious ( Principal Investigator judgment ) mental illness , Receipt investigational medicinal product within 30 day plan date unfractionated heparin and/or study drug administration , Positive serology human immunodeficiency virus 1 2 ( HIV1 2 ) , hepatitis B surface antigen ( HBsAg ) hepatitis C virus ( HCV ) , Fever great 37.5Â°C time plan dosing , Suspicion recent history alcohol substance abuse , Donated blood blood product within past 30 day , Women pregnant breastfeeding , Employee family member investigational site , Subjects currently smoke cigarette , cigar , pipe chew tobacco product use tobacco product 30 day prior screen , Subjects either unwilling agree refrain use find use : 1 . Alcohol , caffeine , xanthinecontaining food beverage , nicotine product overthecounter medication exception Tylenol 24 hour prior dose throughout confinement period 2 . Prescription medication 14 day prior 7 day post treatment ( exclude hormonal contraceptive ) 3 . Hormonal contraceptive without concomitant use doublebarrier contraceptive ( condom , diaphragm spermicide ) period 7 day prior 30 day post treatment Subjects take aspirin nonsteroidal antiinflammatory agent , either prescription overthecounter , within 10 day treatment , Subjects know allergic untoward effect use unfractionated heparin , Subjects previous exposure Bendavia , Subjects expect undergo surgical procedure within 14 day completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>